Conference Track

Diagnostics and New Drugs

Source: CCO Independent Conference Coverage of the 2004 Annual Meeting of The American Association for the Study of Liver Diseases*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Capsule Summaries

Diagnostics

Qualitative TMA Assay for HCV Differentiates Nonresponders from Relapsers After Treatment
Noninvasive Methods to Stage Liver Disease Vary in Sensitivity, Specificity, and Predictive Value
Transient Elastography Plus Biochemical Tests Potentially as Sensitive as Liver Biopsy
Transient Elastography (Liver Stiffness Measurement) Promising Noninvasive Alternative to Liver Biopsy to Assess Fibrosis in Chronic Hepatitis C
Chemiluminescence Antibody Assay Accurately Monitored Viral Response to Treatment in HCV Patients in Pilot Study

New Drugs

Expert Analysis

Diagnostics and New Drugs

Program Director: Patrick J. Lynch, MD

Faculty:

Geoffrey M. Dusheiko, MD, FCP(SA), FRCP
Robert G. Gish, MD
Jean-Michel Pawlotsky, MD, PhD

Learning Objectives

Upon completion of this activity, participants should be able to:

Review studies of invasive and noninvasive diagnostic tests of liver fibrosis and inflammation
Evaluate studies of the sensitivity and specificity of current and new tests for the quantitative and qualitative diagnosis of viral hepatitis
Discuss recent studies of drugs in early-stage clinical trials for the treatment of viral hepatitis

Earn CME credit by reading the expert analysis and commentary on Diagnostics and New Drugs.

Topics covered include:

Novel Tools for Assessing Functional Liver Activity
Innovations in Measuring Viral Hepatitis C
HCV Core Antigen Enzyme Immunoassay (EIA)
Clevudine
Combination vs Single-Agent Therapy
Entecavir
Tenofovir
Liver-Targeted Prodrugs: Remofovir and Viramidine

CME CREDIT INFORMATION

Release Date: 12/21/04

Expiration Date: 12/20/05

Physicians: maximum of 2.0 AMA PRA Category 1 Credits™

Registered Nurses: 3.6 Nursing CE credits

Pharmacists: 3.0 contact hours (0.3 CEUs)

Status: Please log in to view status

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.